Search

Author/Creator Linehan, David C

1. GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity. Issue 7 (19th August 2021)

Authors:
Ruffolo, Luis I; Jackson, Katherine M; Kuhlers, Peyton C; Dale, Benjamin S; Figueroa Guilliani, Nathania M; Ullman, Nicholas A; Burchard, Paul R; Qin, Shuyang S; Juviler, Peter G; Keilson, Jessica Millian; Morrison, Ashley B; Georger, Mary; Jewell, Rachel; Calvi, Laura M; Nywening, Timothy M; O'D...
Journal:
Gut
Issue:
Volume 71:Issue 7(2022)
Page Start:
1386
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Recruitment of CCR2+ tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer. (2nd September 2018)

Authors:
Grossman, Julie G; Nywening, Timothy M; Belt, Brian A; Panni, Roheena Z; Krasnick, Bradley A; DeNardo, David G; Hawkins, William G; Goedegebuure, S Peter; Linehan, David C; Fields, Ryan C
Journal:
Oncoimmunology
Issue:
Volume 7:Number 9(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma. Issue 6 (1st December 2017)

Authors:
Nywening, Timothy M; Belt, Brian A; Cullinan, Darren R; Panni, Roheena Z; Han, Booyeon J; Sanford, Dominic E; Jacobs, Ryan C; Ye, Jian; Patel, Ankit A; Gillanders, William E; Fields, Ryan C; DeNardo, David G; Hawkins, William G; Goedegebuure, Peter; Linehan, David C
Journal:
Gut
Issue:
Volume 67:Issue 6(2018)
Page Start:
1112
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Issue 5 (May 2016)

Authors:
Nywening, Timothy M; Wang-Gillam, Andrea; Sanford, Dominic E; Belt, Brian A; Panni, Roheena Z; Cusworth, Brian M; Toriola, Adetunji T; Nieman, Rebecca K; Worley, Lori A; Yano, Motoyo; Fowler, Kathryn J; Lockhart, A Craig; Suresh, Rama; Tan, Benjamin R; Lim, Kian-Huat; Fields, Ryan C; Strasberg, S...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 5(2016:May)
Page Start:
651
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer. Issue 7 (17th July 2022)

Authors:
Ye, Jian; Mills, Bradley N; Qin, Shuyang S; Garrett-Larsen, Jesse; Murphy, Joseph D; Uccello, Taylor P; Han, Booyeon J; Vrooman, Tara G; Johnston, Carl J; Lord, Edith M; Belt, Brian A; Linehan, David C; Gerber, Scott A
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 7(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗